Investigating the response of prostatic cancer to endocrine therapy
Shimazaki, J.; Isaka, S.; Akimoto, S.; Sumiya, H.; Masai, M.; Higa, T.
Progress in Clinical and Biological Research 357: 59-67
1990
ISSN/ISBN: 0361-7742 PMID: 1699239 Document Number: 362523
The presence of androphilic protein identified histochemically with R 1881-CMO-BSA-FITC correlated with response to endocrine therapy and prognosis. Ras P21 was not a useful indicator of the subsequent course of the disease. Conventional X ray assessment of boney metastases still seems of use in monitoring overall progress of the disease.
Document emailed within 1 workday
Related Documents
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Shimazaki, J.; Fuse, H.; Ohshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K.; Saito, Y. 1991: Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis Hinyokika Kiyo. Acta Urologica Japonica 37(11): 1505-1510Rubens, R.D.; Hayward, J.L. 1980: Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2922-2924
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Nardelli, G.B.; Lamaina, V.; Siliotti, F. 1986: Estrogen and progesterone receptors status in the prediction of response of breast cancer to endocrine therapy (preliminary report) European Journal of Gynaecological Oncology 7(3): 151-158
Kihara, M.; Miyauchi, A. 2008: A case of elderly breast cancer achieving partial response by letrozole with stable disease to anastrozole as neoadjuvant endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(4): 687-690
DeWys, W.D.; Allegra, J.C.; Simon, R.; Lippman, M.B. 1980: A proposed model for the prediction of response to endocrine therapy in breast cancer from the estrogen receptor status of one site and the number of metastatic sites Cancer Research 40(7): 2423-2427
Athens, A.T.; Grimaldi, A.M. 1983: Responses of metastatic prostatic carcinoma to endocrine therapy: report of a case Journal of the American Osteopathic Association 83(4): 307-311
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
McGuire, W.L. 1978: Hormone receptors: their role in predicting prognosis and response to endocrine therapy Seminars in Oncology 5(4): 428-433
Machida, T.; Ikemoto, I. 1987: Hormone therapy of male genital cancer (prostatic cancer) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2845-2852
Mayer, F.J.; Crawford, E.D. 1994: The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy Urologic Clinics of North America 21(4): 707-715
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Barrack, E.R.; Brendler, C.B.; Walsh, P.C. 1987: Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment Progress in Clinical and Biological Research 243a: 79-97
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Huzell, L.; Persson, M.; Simonsson, M.; Markkula, A.; Ingvar, C.; Rose, C.; Jernström, H. 2015: History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response Breast Cancer Research and Treatment 149(2): 505-515
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Fujita, K. 1986: Progress in cancer therapy. 12. Prostatic cancer Nursing Technique 32(16): 2084-2087
Jonat, W.; Maass, H. 1987: Endocrine therapy of breast cancer Zentralblatt für Gynakologie 109(10): 617-627
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R. 1980: Hormone therapy in prostatic cancer Acta Urologica Belgica 48(1): 98-105